KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Comment on: ALBAN (GETUG-AFU 37): a phase III, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).

R Contieri, V Mollica, S F Shariat, B Pradere

Ann Oncol 37(5) 747-749

PMID41539604
PMCID-
DOI10.1016/j.annonc.2026.01.003
发表日期2026-01-15
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。